Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease
- 1 September 2016
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 68 (10), 999-1009
- https://doi.org/10.1016/j.jacc.2016.06.024
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score IIThe Lancet, 2013
- Meta-Analysis of Three Randomized Trials and Nine Observational Studies Comparing Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery DiseaseThe American Journal of Cardiology, 2012
- Everolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Artery StenosisJACC: Cardiovascular Interventions, 2012
- Drug-Eluting Stent for Left Main Coronary Artery DiseaseJACC: Cardiovascular Interventions, 2012
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventionsJournal of the American College of Cardiology, 2011
- Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery DiseaseThe New England Journal of Medicine, 2011
- Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results From the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) RegistryJournal of the American College of Cardiology, 2010
- 5-Year Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Versus Coronary Artery Bypass Graft for Unprotected Left Main Coronary Artery Lesions: The Milan ExperienceJACC: Cardiovascular Interventions, 2010
- Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) TrialCirculation, 2010
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseThe New England Journal of Medicine, 2009